Hikma's Advair Generic Gets Further Delayed Post author:Sam Post published:March 11, 2018 Post category:BioPharma Hikma Pharmaceuticals generic version of Advair has hit a stumbling block with the FDA. Source: BioSpace You Might Also Like ImmusanT, Inc. Presents Data From Multiple Studies Supporting Continued Development Of Nexvax2 September 10, 2017 3 Biotechs to Load Up on This Holiday Season November 30, 2017 Internationally Renowned City of Hope Scientist Ph.D., Named Chair In Diabetes & Drug Discovery February 9, 2017
ImmusanT, Inc. Presents Data From Multiple Studies Supporting Continued Development Of Nexvax2 September 10, 2017
Internationally Renowned City of Hope Scientist Ph.D., Named Chair In Diabetes & Drug Discovery February 9, 2017
